NDC 69097-830

fosaprepitant

Fosaprepitant

fosaprepitant is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Fosaprepitant Dimeglumine.

Product ID69097-830_5d828458-1e4f-4e36-9e9f-74c846722b04
NDC69097-830
Product TypeHuman Prescription Drug
Proprietary Namefosaprepitant
Generic NameFosaprepitant
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2019-09-05
Marketing CategoryANDA / ANDA
Application NumberANDA212309
Labeler NameCipla USA Inc.
Substance NameFOSAPREPITANT DIMEGLUMINE
Active Ingredient Strength150 mg/5mL
Pharm ClassesNeurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 69097-830-37

1 VIAL, SINGLE-DOSE in 1 CARTON (69097-830-37) > 5 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2019-09-05
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69097-830-37 [69097083037]

fosaprepitant INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA212309
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-09-05

Drug Details

Active Ingredients

IngredientStrength
FOSAPREPITANT DIMEGLUMINE150 mg/5mL

Pharmacological Class

  • Neurokinin 1 Antagonists [MoA]
  • Substance P/Neurokinin-1 Receptor Antagonist [EPC]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Cytochrome P450 2C9 Inducers [MoA]
  • Cytochrome P450 3A4 Inducers [MoA]
  • Neurokinin 1 Antagonists [MoA]
  • Substance P/Neurokinin-1 Receptor Antagonist [EPC]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Cytochrome P450 2C9 Inducers [MoA]
  • Cytochrome P450 3A4 Inducers [MoA]

NDC Crossover Matching brand name "fosaprepitant" or generic name "Fosaprepitant"

NDCBrand NameGeneric Name
0338-0008FosaprepitantFosaprepitant Dimeglumine
0591-4385Fosaprepitantfosaprepitant
0781-3497FosaprepitantFosaprepitant
16714-120FosaprepitantFosaprepitant
16714-248FosaprepitantFosaprepitant dimeglumine
16714-929FosaprepitantFosaprepitant
16729-240FosaprepitantFOSAPREPITANT
25021-784FosaprepitantFosaprepitant Dimeglumine
31722-165FosaprepitantFosaprepitant dimeglumine
43598-859FosaprepitantFosaprepitant
43598-948FosaprepitantFosaprepitant
60505-6105FosaprepitantFosaprepitant
63323-972FosaprepitantFOSAPREPITANT
67457-888fosaprepitantfosaprepitant
67457-889fosaprepitantfosaprepitant
68001-421FosaprepitantFosaprepitant
68001-517fosaprepitantfosaprepitant
68001-523FosaprepitantFosaprepitant dimeglumine
68180-690FosaprepitantFosaprepitant
69097-830fosaprepitantfosaprepitant
69539-034FosaprepitantFosaprepitant
69539-181FosaprepitantFosaprepitant
70625-300FosaprepitantFosaprepitant Dimeglumine
72205-026FosaprepitantFosaprepitant
71839-104fosaprepitantfosaprepitant
71288-418FOSAPREPITANTFOSAPREPITANT
70860-780FosaprepitantFosaprepitant
72606-569FosaprepitantFosaprepitant
70710-1615fosaprepitantfosaprepitant
72205-054FosaprepitantFosaprepitant
70860-782FosaprepitantFosaprepitant
72603-106FOSAPREPITANTFOSAPREPITANT
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.